Roivant Sciences (ROIV) Amortization of Deferred Charges (2021 - 2025)

Roivant Sciences' Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $6.4 million for Q4 2025.

• Quarterly Amortization of Deferred Charges rose 31.64% year-over-year to $6.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.2 million (up 15.98% YoY) and the FY2026 annual result came in at $8.3 million, up 20.94% from the prior year.
• Amortization of Deferred Charges was $6.4 million for Q4 2025 at Roivant Sciences, up from $1.9 million in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $6.4 million in Q4 2025 and bottomed at $1.6 million in Q3 2024.
• A 5-year average of $3.3 million and a median of $2.0 million in 2022 frame the typical range for Amortization of Deferred Charges.
• Annual changes were most pronounced in 2023 — Amortization of Deferred Charges retreated 22.56% — and 2025, when it soared 31.64%.
• Roivant Sciences' Amortization of Deferred Charges stood at $5.4 million in 2021, then rose by 11.2% to $6.0 million in 2022, then slipped by 16.01% to $5.0 million in 2023, then retreated by 3.49% to $4.9 million in 2024, then surged by 31.64% to $6.4 million in 2025.
• Business Quant data shows ROIV's Amortization of Deferred Charges at $6.4 million in Q4 2025, $1.9 million in Q3 2025, and $1.9 million in Q2 2025.